A case of segmental stiff skin syndrome treated with systemic losartan. 2018

Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
Department of Dermatology, CHU de Quebec, Laval University, Quebec, QC, Canada.

Stiff skin syndrome (SSS) is a rare, autosomal dominant cutaneous disorder with progressive, symmetric, sclerotic skin changes of the shoulders, hips, and thighs. In a recent publication, a distinct segmental variant of SSS was proposed. In this report we discuss the case of a boy with segmental SSS and review the current literature.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003286 Contracture Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint. Contractures
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012873 Skin Diseases, Genetic Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism. Genetic Skin Diseases,Disease, Genetic Skin,Diseases, Genetic Skin,Genetic Skin Disease,Skin Disease, Genetic
D047228 Angiotensin II Type 1 Receptor Blockers Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. Angiotensin II Type 1 Receptor Antagonist,Angiotensin II Type 1 Receptor Blocker,Sartan,Angiotensin 2 Type 1 Receptor Antagonists,Angiotensin II Type 1 Receptor Antagonists,Sartans,Selective Angiotensin II Receptor Antagonists,Type 1 Angiotensin Receptor Antagonists,Type 1 Angiotensin Receptor Blockers
D019808 Losartan An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol,Cozaar,DuP-753,Losartan Monopotassium Salt,Losartan Potassium,MK-954,MK954,DuP 753,DuP753,MK 954,Monopotassium Salt, Losartan,Potassium, Losartan,Salt, Losartan Monopotassium

Related Publications

Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
July 2020, Clinical and experimental dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
August 2021, The Australasian journal of dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
April 2023, International journal of dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
July 2016, Journal of the American Academy of Dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
January 2003, Pediatric dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
January 1991, Annales de dermatologie et de venereologie,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
January 2011, Anais brasileiros de dermatologia,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
January 2021, Clinical and experimental dermatology,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
February 1971, Pediatrics,
Nicole Maillet-Lebel, and Victor Kokta, and Jerome Coulombe, and Julie Powell
January 1989, Annales de dermatologie et de venereologie,
Copied contents to your clipboard!